The current streaming landscape at Netflix is a study in contrasts, defined by ruthless cost-benefit analyses that can end a show’s life prematurely or revive a global phenomenon after a long hiatus. This week, the platform’s strategy came into sharp focus with news regarding two high-profile series: the definitive cancellation of the mythology drama KAOS and the long-awaited production updates for the second season of the Korean hit All of Us Are Dead.
The Fall of Olympus
Just one year after its premiere, the Jeff Goldblum-led series KAOS has effectively vanished from the cultural conversation. Pitched as a dark, comedic, and modern retelling of Greek mythology, the show struggled to justify its existence beyond a single season. Despite generating initial buzz and landing on Netflix’s top 10 charts for roughly a month, the streamer moved quickly to axe the project, leaving fans with no hope for a sophomore outing.
The decision has left industry observers and audiences alike scratching their heads. On paper, the show had everything required for a hit: a star-studded cast featuring Goldblum as a neurotically modern Zeus, alongside heavy hitters like Janet McTeer, Cliff Curtis, Billie Piper, and David Thewlis. However, the show’s ambition may have been its undoing. The production demanded a massive budget to support its elaborate visual effects, sets, and costuming required to build an alternate, modernized version of Greece.
The Metrics of Cancellation
Ultimately, there is no single reason for the cancellation, though the intersection of viewership and cost appears to be the primary culprit. While KAOS secured a respectable 78% aggregate rating on Rotten Tomatoes, it failed to become the kind of smash hit required to sustain such an expensive production. In the current streaming economy, a show that performs “just fine” is often on the chopping block if its price tag is too high.
Interestingly, KAOS holds the dubious distinction of being the most-watched canceled series on Netflix in the latter half of 2024. It occupied a strange space in the catalog—a unique blend of supernatural drama, intricate narrative webs, and dark British humor. While this distinct flavor earned it a devoted cult following, it likely made the series difficult for executives to market to a broader audience for a second season.
The Undead Rises Again
While KAOS serves as a cautionary tale of high-budget risks, the news coming out of South Korea paints a very different picture of streaming success. Netflix has officially confirmed that All of Us Are Dead will return for a second season, continuing the trend of massive global investment in Korean content following the trailblazing success of Squid Game.
The first season, which dropped in January 2022, was a juggernaut, holding the top spot in Netflix’s charts across 91 countries for two weeks. The premise—a high school becoming ground zero for a zombie virus outbreak—resonated globally, forcing students into brutal, life-threatening survival scenarios. Given this performance, a renewal was inevitable, though fans will have to exercise patience.
Production Timeline and Cast Expectations
For those eager to dive back into the horror, the wait will be significant. Production for the second season is scheduled to take place throughout 2025, which places the likely release window in early 2026.
Because the series functions as a direct continuation of the survival thriller, the core ensemble is expected to return. While the high body count of the first season thinned the herd, viewers can expect to see familiar faces. The prospective returning cast list includes Lee Sang-hee, Kim Ju-a, Ham Sung-min, and breakout stars like Lee Yoo-mi and Park Ji-hu, alongside the broader ensemble that survived the initial outbreak.
As Netflix continues to refine its library, the divergent paths of these two shows highlight the platform’s current mandate: distinctiveness alone isn’t enough to save a show like KAOS, but global viral impact, as seen with All of Us Are Dead, guarantees a future—no matter how long the production takes.
About the Author
